Published in Comput Med Imaging Graph on March 03, 2011
Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation (2005) 6.68
A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation (1997) 4.05
Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol (1996) 2.78
An 8 1/2-year clinical experience with surgery for atrial fibrillation. Ann Surg (1996) 2.43
Intracardiac echo-guided image integration: optimizing strategies for registration. J Cardiovasc Electrophysiol (2007) 1.85
The surgical treatment of atrial fibrillation. IV. Surgical technique. J Thorac Cardiovasc Surg (1991) 1.83
Integrated electroanatomic mapping with three-dimensional computed tomographic images for real-time guided ablations. Circulation (2006) 1.79
Image integration using NavX Fusion: initial experience and validation. Heart Rhythm (2008) 1.73
The impact of image integration on catheter ablation of atrial fibrillation using electroanatomic mapping: a prospective randomized study. Eur Heart J (2008) 1.73
Integration of cardiac CT/MR imaging with three-dimensional electroanatomical mapping to guide catheter manipulation in the left atrium: implications for catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2006) 1.54
On the accuracy of CartoMerge for guiding posterior left atrial ablation in man. Heart Rhythm (2007) 1.34
Impact of integration of multislice computed tomography imaging into three-dimensional electroanatomic mapping on clinical outcomes, safety, and efficacy using radiofrequency ablation for atrial fibrillation. Pacing Clin Electrophysiol (2007) 1.32
Catheter ablation of atrial fibrillation using the Navx-/Ensite-system and a CT-/MRI-guided approach. Clin Res Cardiol (2009) 1.31
Laser range scanning for image-guided neurosurgery: investigation of image-to-physical space registrations. Med Phys (2008) 1.21
Computed tomography-fluoroscopy overlay evaluation during catheter ablation of left atrial arrhythmia. Europace (2008) 1.14
Feasibility and validation of registration of three-dimensional left atrial models derived from computed tomography with a noncontact cardiac mapping system. Heart Rhythm (2005) 1.14
An event-driven distributed processing architecture for image-guided cardiac ablation therapy. Comput Methods Programs Biomed (2009) 1.11
New generation of electro-anatomic mapping: full intracardiac ultrasound image integration. Europace (2008) 1.04
Validation of computed tomography image integration into the EnSite NavX mapping system to perform catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2008) 1.02
Real-time 3-dimensional transesophageal echocardiography during left atrial radiofrequency catheter ablation for atrial fibrillation. Circ Cardiovasc Imaging (2008) 1.01
Computed tomography model-based treatment of atrial fibrillation and atrial macro-re-entrant tachycardia. Europace (2008) 0.98
Stereotactic catheter navigation using magnetic resonance image integration in the human heart. Heart Rhythm (2005) 0.93
Image integration using intracardiac ultrasound to guide catheter ablation of atrial fibrillation. Heart Rhythm (2008) 0.88
Images in cardiovascular medicine. Integration of 3-dimensional cardiac computed tomography images with real-time electroanatomic mapping to guide catheter ablation of atrial fibrillation. Circulation (2005) 0.86
A randomized prospective comparison of CartoMerge and CartoXP to guide circumferential pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation. Chin Med J (Engl) (2008) 0.85
Catheter ablation of atrial fibrillation guided by registered computed tomographic image of the atrium. Heart Rhythm (2005) 0.85
Cardiac image registration of the left atrium and pulmonary veins. Heart Rhythm (2007) 0.85
Image integration in catheter ablation of atrial fibrillation. Europace (2008) 0.82
Novel ICE-guided registration strategy for integration of electroanatomical mapping with three-dimensional CT/MR images to guide catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2008) 0.79
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med (2009) 17.17
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med (2003) 13.29
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med (2014) 10.54
Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation (2002) 4.99
Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol (2004) 4.62
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 4.57
Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res (2004) 4.02
CRUISE: cortical reconstruction using implicit surface evolution. Neuroimage (2004) 3.74
Drug-eluting coronary-artery stents. N Engl J Med (2013) 3.69
Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis. J Am Coll Cardiol (2011) 3.66
Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. J Am Soc Nephrol (2010) 3.47
Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J (2011) 3.29
Incidence, retrieval methods, and outcomes of stent loss during percutaneous coronary intervention: a large single-center experience. Catheter Cardiovasc Interv (2005) 3.20
Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective. Thromb Haemost (2011) 3.16
Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol (2007) 2.88
Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events. Circulation (2003) 2.81
A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res (2008) 2.76
Transcatheter aortic valve implantation: assessing the learning curve. JACC Cardiovasc Interv (2011) 2.63
Myocardial bridging. Eur Heart J (2005) 2.56
Trends in cause of death after percutaneous coronary intervention. Circulation (2014) 2.52
Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol (2003) 2.52
Emergency coronary artery bypass surgery for percutaneous coronary interventions: changes in the incidence, clinical characteristics, and indications from 1979 to 2003. J Am Coll Cardiol (2005) 2.51
Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc Interv (2010) 2.51
Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial. J Am Coll Cardiol (2007) 2.47
Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol. Circulation (2007) 2.47
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol (2012) 2.44
Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation (2008) 2.42
Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation. Am Heart J (2004) 2.42
Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA (2004) 2.32
Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Circulation (2007) 2.31
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2014) 2.30
Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation (2006) 2.29
Chronic total occlusion angioplasty in the United States. JACC Cardiovasc Interv (2009) 2.24
Intravascular ultrasound-guided treatment for angiographically indeterminate left main coronary artery disease: a long-term follow-up study. J Am Coll Cardiol (2005) 2.21
Treatment of saphenous vein bypass grafts with ultrasound thrombolysis: a randomized study (ATLAS). Circulation (2003) 2.21
Effect of peripheral arterial disease in patients undergoing percutaneous coronary intervention with intracoronary stents. Mayo Clin Proc (2004) 2.11
Mapping techniques for aligning sulci across multiple brains. Med Image Anal (2004) 2.04
Volume-outcome relationships for percutaneous coronary interventions in the stent era. Circulation (2005) 2.03
The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol (2002) 2.03
Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation (2002) 2.00
Rheolytic thrombectomy with Angiojet in thrombus-containing lesions. Catheter Cardiovasc Interv (2002) 1.98
Structural determinants of vertebral fracture risk. J Bone Miner Res (2007) 1.97
The history of the German Cardiac Society and the American College of Cardiology and their two founders. J Am Coll Cardiol (2013) 1.97
Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol (2007) 1.91
High resolution multidetector CT-aided tissue analysis and quantification of lung fibrosis. Acad Radiol (2007) 1.90
Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality. J Am Coll Cardiol (2006) 1.90
Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation (2002) 1.88
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation (2004) 1.87
Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). Circulation (2012) 1.87
Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice. J Am Coll Cardiol (2009) 1.87
A risk score to predict in-hospital mortality for percutaneous coronary interventions. J Am Coll Cardiol (2006) 1.84
Clinical determinants of radiation dose in percutaneous coronary interventional procedures: influence of patient size, procedure complexity, and performing physician. JACC Cardiovasc Interv (2011) 1.80
Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience. J Am Coll Cardiol (2008) 1.78
Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation (2012) 1.77
Comparison of coronary artery stenting outcomes in the eras before and after the introduction of drug-eluting stents. Circulation (2008) 1.77
Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data. Eur J Cardiothorac Surg (2011) 1.77
Long-term outcomes of fractional flow reserve-guided vs. angiography-guided percutaneous coronary intervention in contemporary practice. Eur Heart J (2013) 1.76
Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc (2002) 1.74
Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational Research. JACC Cardiovasc Interv (2010) 1.74
Validation of Mayo Clinic risk adjustment model for in-hospital complications after percutaneous coronary interventions, using the National Heart, Lung, and Blood Institute dynamic registry. J Am Coll Cardiol (2003) 1.74
Coronary stent restenosis in patients treated with cilostazol. Circulation (2005) 1.73
Factors associated with 30-day readmission rates after percutaneous coronary intervention. Arch Intern Med (2011) 1.70
Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic. J Am Coll Cardiol (2007) 1.68
Efficacy and safety of atrasentan in patients with cardiovascular risk and early atherosclerosis. Hypertension (2008) 1.67
Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv (2011) 1.66
The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial. Am Heart J (2006) 1.65
Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. Eur Heart J (2006) 1.63
Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry. J Am Coll Cardiol (2002) 1.62
Myocardial bridging in adult patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (2003) 1.62
Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty. Am Heart J (2004) 1.60
Long-term mortality of coronary artery bypass grafting and bare-metal stenting. Ann Thorac Surg (2011) 1.60
30-day readmission for patients undergoing percutaneous coronary interventions in New York state. JACC Cardiovasc Interv (2011) 1.59
Enhanced external counterpulsation for ischemic heart disease: what's behind the curtain? J Am Coll Cardiol (2003) 1.59
Age- and sex-specific differences in the factor of risk for vertebral fracture: a population-based study using QCT. J Bone Miner Res (2006) 1.58
Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering. Circulation (2002) 1.57
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary. Circ Cardiovasc Interv (2011) 1.56
The truth and consequences of the COURAGE trial. J Am Coll Cardiol (2007) 1.55
Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents. Circulation (2004) 1.54
Sex differences in atheroma burden and endothelial function in patients with early coronary atherosclerosis. Eur Heart J (2008) 1.53
Medical device innovation: prospective solutions for an ecosystem in crisis. Adding a professional society perspective. JACC Cardiovasc Interv (2012) 1.53
Comparative outcomes for patients who do and do not undergo percutaneous coronary intervention for stable coronary artery disease in New York. Circulation (2012) 1.52
Percutaneous coronary intervention at centers with and without on-site surgery: a meta-analysis. JAMA (2011) 1.51
Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial. Catheter Cardiovasc Interv (2012) 1.51
Staged versus one-time complete revascularization with percutaneous coronary intervention for multivessel coronary artery disease patients without ST-elevation myocardial infarction. Circ Cardiovasc Interv (2013) 1.51
Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation (2004) 1.51
Turf wars and silos-joined at the hip: what can be done? Catheter Cardiovasc Interv (2007) 1.50
Low-risk percutaneous coronary interventions without on-site cardiac surgery: two years' observational experience and follow-up. Am Heart J (2003) 1.50
Location of femoral artery access and correlation with vascular complications. Catheter Cardiovasc Interv (2011) 1.50
Clinical practice. Hypertrophic obstructive cardiomyopathy. N Engl J Med (2004) 1.50
Transcatheter valve therapy: a professional society overview from the American College of Cardiology Foundation and the Society of Thoracic Surgeons. Ann Thorac Surg (2011) 1.49
Drug-eluting versus bare-metal stents in the treatment of patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv (2008) 1.49